ORYZON announces FDA Orphan Drug Designation granted to iadademstat for treatment of Small... 08/06/2022 Healthcare Access to innovation Corporate Now has orphan drug designation for SCLC and AML Partners - Oryzon Genomics
Natac opens new Singapore office to locally serve its APAC customers 07/06/2022 Access to innovation International BioSpain Communication Corporate Madrid, Wednesday, June 1st, 2022— Natac has opened an office in central Singapore, to expand its sales, logistics and... Partners - Natac Group
Kimitec publishes its new products for the month of May 02/06/2022 Access to innovation Agrifood Kimitec is a company dedicated to research and development in the field of crop bioprotection and microbiological... Partners
Nuage Therapeutics appoints biotech entrepreneur and executive Judit Anido as CEO 10/05/2022 Healthcare Access to innovation Corporate Judit Anido joins Nuage Therapeutics as co-founder and CEO and becomes member of the Board of Directors Partners - Asabys Partners
ORYZON to give updates on corporate progress in May 29/04/2022 Access to innovation Corporate Oryzon Genomics, S.A., announced today that its management will give an update on corporate progress at several... Partners - Oryzon Genomics
The 2050 Challenge: A Shift In Food Production. LINNA®, Natural Intelligence Powered By Ar... 20/04/2022 Access to innovation Agrifood Aiming to protect human health and the environment, Kimitec, has been researching and developing for the last 15 years... Partners
DIVERSA launches DIVTECH kits, a new solution for the cellular delivery of molecules, and ... 20/04/2022 Healthcare Access to innovation Drug discovery After just three months since the incorporation of DIVERSA Technologies, the company has already struck some deals that... Partners - DIVERSA Technologies
Biofish 3000 yake: the only method on the market for the objective determination of the de... 20/04/2022 Access to innovation BIOLAN launches a new analytical solution that allows to quantitatively classify the degree of YAKE in tuna, without the... Partners - Biolan
ZeClinics partners with the Institut de la Vision to test in zebrafish the most cutting-ed... 20/04/2022 Healthcare Access to innovation ZeClinics has recently started a new collaboration with the Institut de la Vision, led by Filippo del Bene, to test in... Partners - ZeClinics
A perfect case study of CRO – Pharma successful alliance 20/04/2022 Healthcare Access to innovation ZeClinics and Dompé Farmaceutici started this collaboration a few years ago, in an effort to validate the use of... Partners - ZeClinics
